$AMPX Cashflow Statement | Understand Stock

$AMPX

$8.88 +$0.53 (6.29%) Live

$AMPX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Amortization of deferred costs
Non-cash operating lease expense
Loss from disposal of property, plant and equipment
Gain on forgiveness of PPP loan
Loss on retirement of property, plant and equipment
Loss on write-off of deferred stock issuance costs
Impairment and other
Other non-cash items
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Deferred costs
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued and other current liabilities
Deferred revenue
Deferred grant
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net
At Market Issuance Sales Agreement
Common Stock Purchase Agreement
Total proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net

Proceeds from issuance of common stock upon exercise of stock warrants
Capital contributions from Amprius Holdings
Payment of equity financing costs
At Market Issuance Sales Agreement
Total payment of equity financing costs
Proceeds from issuance of common stock in connection with Business Combination and PIPE investment
Payment of transaction and issuance costs in connection with Business Combination and PIPE investment
Proceeds from exercise of stock options
Net cash provided by financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash equivalents
Net increase in cash, cash equivalents and restricted cash equivalents
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents
Cash, cash equivalents and restricted cash equivalents, beginning of year
Cash, cash equivalents and restricted cash equivalents, end of year
Supplemental non-cash investing and financing activities:
Operating lease liabilities and right-of-use assets upon adoption of ASC 842
Unpaid purchases of property, plant and equipment
Unpaid financing costs in connection with a stock purchase agreement
Increase in fair value of modified stock warrants
Cancellation and retirement of common stock

Reconciliation of cash, cash equivalents and restricted cash equivalents shown on the consolidated balance sheets:
Cash and cash equivalents
Restricted cash included in other assets
Restricted cash equivalents included in prepaid expenses and other current assets
Restricted cash equivalents included in other assets

Comments